Furiex Pharmaceuticals, Inc. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 7, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.Financial_Report.xls
10-K - FORM 10-K - Furiex Pharmaceuticals, Inc.d276649d10k.htm
EX-32.1 - CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 - Furiex Pharmaceuticals, Inc.d276649dex321.htm
EX-32.2 - CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906 - Furiex Pharmaceuticals, Inc.d276649dex322.htm
EX-21.1 - SUBSIDIARIES OF FURIEX PHARMACEUTICALS, INC. - Furiex Pharmaceuticals, Inc.d276649dex211.htm
EX-31.1 - CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 - Furiex Pharmaceuticals, Inc.d276649dex311.htm
EX-31.2 - CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 - Furiex Pharmaceuticals, Inc.d276649dex312.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in Registration Statement No. 333-167552 on Form S-8 of our reports dated March 7, 2012, relating to the combined and consolidated financial statements of Furiex Pharmaceuticals, Inc. and subsidiaries (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2011.

 

/s/ DELOITTE & TOUCHE LLP
Raleigh, North Carolina

 

March 7, 2012

Furiex Pharmaceuticals, Inc. Reports